ATC code - A07EC02
UkraineMesalazine
-
Form: tablets, modified release
Active substance Dosage mesalazine 1600 mg ATC code: A07EC02
Manufacturer: Tilots Pharma AG (manufacturer responsible for batch release)
-
Form: tablets, coated, enteric-coated
Active substance Dosage mesalazine 400 mg ATC code: A07EC02
Manufacturer: Haupt Pharma Wülfling GmbH (manufacturing of unpackaged products, primary and secondary packaging)
-
Form: tablets, coated, enteric-coated
Active substance Dosage mesalazine 800 mg ATC code: A07EC02
Manufacturer: Haupt Pharma Wülfling GmbH (manufacturing of unpackaged products, primary and secondary packaging)
-
Form: suppositories, rectal
Active substance Dosage mesalazine 500 mg ATC code: A07EC02
Manufacturer: Tilots Pharma AG (manufacturer responsible for batch release)
-
Form: tablets, coated, enteric-coated
Active substance Dosage mesalazine 400 mg ATC code: A07EC02
Manufacturer: San Pharmaceutical Industries Ltd
-
Form: suppositories
Active substance Dosage mesalazine 1000 mg ATC code: A07EC02
Manufacturer: Kusum HealthCare Pvt Ltd
-
Form: suppositories, rectal
Active substance Dosage mesalazine 1000 mg ATC code: A07EC02
Manufacturer: Ferring International Center SA (manufacturing)
-
Form: tablets, extended-release
Active substance Dosage mesalazine 500 mg ATC code: A07EC02
Manufacturer: Ferring International Center SA (manufacturing)
-
Form: granules, prolonged action
Active substance Dosage mesalazine 1 g ATC code: A07EC02
Manufacturer: Ferring International Center SA (responsible for manufacturing, primary and secondary packaging, quality control)
-
Form: granules, prolonged action
Active substance Dosage mesalazine 2 g ATC code: A07EC02
Manufacturer: Ferring International Center SA (responsible for manufacturing, primary and secondary packaging, quality control)
-
Form: suspension, rectal
Active substance Dosage mesalazine 1 g/100 ml ATC code: A07EC02
Manufacturer: Ferring-Lekhiva a.s.
-
Form: granules, gastroresistant, prolonged-release
Active substance Dosage mesalazine 500 mg ATC code: A07EC02
Manufacturer: Dr. Falk Pharma GmbH (manufacturer responsible for batch release of the final product)
-
Form: granules, gastroresistant, prolonged-release
Active substance Dosage mesalazine 1000 mg ATC code: A07EC02
Manufacturer: Dr. Falk Pharma GmbH (manufacturer responsible for batch release of the final product)
-
Form: granules, gastroresistant prolonged-release
Active substance Dosage mesalazine 3 g ATC code: A07EC02
Manufacturer: Dr. Falk Pharma GmbH (responsible for batch release of the final product)
-
Form: granules, gastroresistant prolonged-release
Active substance Dosage mesalazine 1.5 g ATC code: A07EC02
Manufacturer: Dr. Falk Pharma GmbH (responsible for batch release of the final product)
-
Form: suspension, rectal
Active substance Dosage mesalazine 4 g ATC code: A07EC02
Manufacturer: Dr. Falk Pharma GmbH (responsible for batch release of the final product)
-
Form: suppositories, rectal
Active substance Dosage mesalazine 250 mg ATC code: A07EC02
Manufacturer: Dr. Falk Pharma GmbH (responsible for batch release of the final product)
-
Form: suppositories, rectal
Active substance Dosage mesalazine 500 mg ATC code: A07EC02
Manufacturer: Dr. Falk Pharma GmbH (responsible for batch release of the final product)
-
Form: suppositories, rectal
Active substance Dosage mesalazine 1000 mg ATC code: A07EC02
Manufacturer: Dr. Falk Pharma GmbH (Responsible for release of final product batches)
-
Form: tablets, coated, enteric-coated
Active substance Dosage mesalazine 500 mg ATC code: A07EC02
Manufacturer: Dr. Falk Pharma GmbH (manufacturer responsible for batch release of the final product)